Metformin L-citrulline

二甲双胍瓜氨酸

Report date: 2025/09/19 20:01:00

Base Information

Drug NameMetformin L-citrulline
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBecker muscular dystrophyMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsYes
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Hospital Basel
Active IndicationsN/A
Inactive IndicationsBecker muscular dystrophyMuscular Dystrophy, Duchenne

Other Information

ATC CodeN/A
Related LinksN/A